Spinal manifestations of Neurofibromatosis type 1

被引：0
|
作者：
Ben Shofty
Ori Barzilai
Morsi Khashan
Zvi Lidar
Shlomi Constantini
机构：
[1] Tel-Aviv Medical Center and Tel Aviv University,Department of Neurosurgery
[2] The Gilbert Israeli International Neurofibromatosis Center (GIINFC),Department of Neurological Surgery
[3] Memorial Sloan Kettering Cancer Center,Department of Pediatric Neurosurgery, Dana Children’s Hospital
[4] Tel-Aviv Medical Center and Tel Aviv University,undefined
来源：
Child's Nervous System | 2020年 / 36卷
关键词：
NF1; Spine; Neurofibroma; Plexiform; MEK;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2401 / 2408
页数：7
相关论文
共 50 条
  • [41] Neurofibromatosis type 1: Spinal neoplasia without symptoms
    Gulati S.
    Leekha S.
    Gupta A.K.
    Kalra V.
    The Indian Journal of Pediatrics, 2004, 71 (9) : 853 - 855
  • [42] Modulation of spinal deformities in patients with neurofibromatosis Type 1
    Durrani, AA
    Crawford, AH
    Chouhdry, SN
    Saifuddin, A
    Morley, TR
    SPINE, 2000, 25 (01) : 69 - 75
  • [43] Ophthalmological manifestations in type 2 neurofibromatosis
    Chetrit, Mardoche
    Challe, Georges
    Kalamarides, Michel
    Massamba, Nathalie
    Touitou, Valerie
    Bodaghi, Bahram
    LeHoang, Phuc
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (07)
  • [44] Orthopaedic Manifestations of Neurofibromatosis Type I
    Evans, Timothy J.
    Wang, Xia
    Binitie, Odion
    JOURNAL OF THE AMERICAN ACADEMY OF ORTHOPAEDIC SURGEONS, 2022, 30 (23) : E1495 - E1503
  • [45] Clinical manifestations and neurofibromatosis type 1 gene mutations of 25 patients with neurofibromatosis type 1 from 10 Chinese pedigrees
    Chen, Hui
    Lin, Xuefei
    Lian, Shi
    Zhu, Wei
    DERMATOLOGICA SINICA, 2020, 38 (04) : 217 - 220
  • [46] Clinical manifestations and endocrinologic disorders in Neurofibromatosis type 1 (NF1)
    Bergamaschi, Rosalba
    Mazzanti, Laura
    Scarano, Emanuela
    Castiglioni, Laura
    Montanari, Francesca
    Torella, Michele
    Zappulla, Franco
    Cicognani, Alessandro
    HORMONE RESEARCH, 2008, 70 : 148 - 148
  • [47] Neurofibromatosis type 1 system-based manifestations and treatments: a review
    Saleh, Mustafa
    Dib, AlFadel
    Beaini, Sarah
    Saad, Charbel
    Faraj, Sary
    El Joueid, Youssef
    Kotob, Yasmine
    Saoudi, Lara
    Emmanuel, Nancy
    NEUROLOGICAL SCIENCES, 2023, 44 (06) : 1931 - 1947
  • [48] Radiological manifestations of abdominopelvic nerve tumours seen in neurofibromatosis type 1
    Ozcan, H. N.
    Karcaaltincaba, M.
    Oguz, B.
    Haliloglu, M.
    CLINICAL RADIOLOGY, 2014, 69 (04) : 431 - 435
  • [49] MEK inhibitors for neurofibromatosis type 1 manifestations: Clinical evidence and consensus
    de Blank, Peter M. K.
    Gross, Andrea M.
    Akshintala, Srivandana
    Blakeley, Jaishri O.
    Bollag, Gideon
    Cannon, Ashley
    Dombi, Eva
    Fangusaro, Jason
    Gelb, Bruce D.
    Hargrave, Darren
    Kim, AeRang
    Klesse, Laura J.
    Loh, Mignon
    Martin, Staci
    Moertel, Christopher
    Packer, Roger
    Payne, Jonathan M.
    Rauen, Katherine A.
    Rios, Jonathan J.
    Robison, Nathan
    Schorry, Elizabeth K.
    Shannon, Kevin
    Stevenson, David A.
    Stieglitz, Elliot
    Ullrich, Nicole J.
    Walsh, Karin S.
    Weiss, Brian D.
    Wolters, Pamela L.
    Yohay, Kaleb
    Yohe, Marielle E.
    Widemann, Brigitte C.
    Fisher, Michael J.
    NEURO-ONCOLOGY, 2022, 24 (11) : 1845 - 1856
  • [50] Reminder for the clinician: abdominal manifestations of type 1 neurofibromatosis are not so uncommon
    Portale, Giuseppe
    Rulli, Roberto
    Spolverato, Ylenia C.
    Mascellino, Paolo
    BMJ CASE REPORTS, 2022, 15 (08)
12345